Jump to content


Targeted Therapy for Lung Cancer

  • Please log in to reply
No replies to this topic

#1 LivingWellWithCML


    Advanced Member

  • Members
  • PipPipPip
  • 60 posts
  • LocationAtlanta, GA

Posted 31 August 2011 - 06:06 AM

More great news on the targeted therapy front and FDA approval ... crizotinib targets the abnormal anaplastic lymphoma kinase (ALK) gene, which is directly linked to a rare form of lung cancer:


Cancer therapy sure is expensive stuff.  I believe Pfizer is charging > $100,000 a month ... in hopes that cancer medications like this one will help replace revenues that will be lost when Lipitor goes generic.

Dan - Atlanta, GA

CML CP Diagnosed March 2011

Gleevec 400mg

1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users